Over the past decade, generics companies have saved the US healthcare system over $1.2 trillion. Globally, generics companies continue to reduce the ...

As large pharmaceutical companies increase their focus on orphan and specialty drugs, they are also seeking ways to reduce operating expenses and ...

Clarkston Consulting attended the Generic Pharmaceutical Association (GPhA) Annual Meeting earlier this month in Miami, Florida. This annual meeting is the ...

Over the past decade, generics companies have saved the US healthcare system over $1 trillion. Globally, generics companies continue to reduce the ...

Over the last two years, Clarkston Consulting has released its study on Quality in Generic Pharmaceuticals. As in the past, ...

Last week Clarkston attended the Generic Pharmaceutical Association Annual Meeting. On behalf of all who attended I want to thank ...

The generic pharmaceutical industry remains one of the most entrepreneurial and dynamic facets of the healthcare system. According to IMS ...

The pharmaceutical industry is undergoing dramatic change. Pricing pressures, pipeline challenges, and emerging global markets are reshaping the way these ...

Welcome to the last installment of Clarkston’s blog series on “The Bermuda Triangle of Growth.”  If you have been following ...

Over the past few months, our blog series has discussed how to diagnose the stagnant growth stage known as the ...

We recently initiated a blog series surrounding a fascinating topic – “The Bermuda Triangle of Growth.” We provided an introduction ...

This blog follows the first in our Bermuda Triangle series, “Is Your Company Stuck in the Bermuda Triangle of Growth?” My task ...